Reviewer comment: In summary, although hepatotoxicity manifesting as elevated aminotransferases is not uncommon with neratinib treatment, the overall risk of neratinib causing drug induced liver injury is low. The product label will include clear instructions on how to monitor patients for signs of hepatotoxicity and management guidelines in terms of dose interruptions and dose reductions.